MRK vs ZTS
By Alex · Tickerpine
Merck & Company, Inc. vs Zoetis Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | MRK | ZTS |
|---|---|---|
| Price | $132.92 | $73.54 |
| Market cap | $327.94B | $30.39B |
| P/E ratio | 106.3 | 12.3 |
| ROE | 6.96% | 64.91% |
| Profit margin | 4.77% | 27.68% |
| Revenue growth | 5.10% | -0.20% |
| Dividend yield | 2.56% | 2.81% |
| Beta | 0.21 | 0.73 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
MRK vs ZTS in plain English
- MRK is the bigger company — about 10.8× the market cap of ZTS.
- ZTS is cheaper on earnings (P/E 12.3 vs 106.3).
- ZTS earns a higher return on equity (65% vs 7%).
- MRK is growing revenue faster (5% vs -0%).
- ZTS has the higher dividend yield (2.81% vs 2.56%).
How would $1,000 have done in each?
MRK return calculator
See what $1,000 in Merck & Company, Inc. would be worth today.
ZTS return calculator
See what $1,000 in Zoetis Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.